We are live on ! Find out more
EIDX

Eidos Therapeutics, Inc. Common Stock
EIDX

Delisted

EIDX was delisted on the 25th of January, 2021.

Back to rankings

45 hedge funds and large institutions have $174M invested in Eidos Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$45.3M
2
Viking Global Investors
Viking Global Investors
Connecticut
+$41.6M
3
PA
Perceptive Advisors
New York
+$14.4M
4
CAM
Cormorant Asset Management
Massachusetts
+$8.09M
5
DM
Deerfield Management
New York
+$6.79M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
Landscape Capital Management
New Jersey
$589K +$607K +28,963 New
DIM
27
DC Investments Management
Virginia
$528K +$544K +25,952 New
ZP
28
Zimmer Partners
New York
$509K +$524K +25,000 New
Northern Trust
29
Northern Trust
Illinois
$281K +$290K +13,825 New
BCM
30
BlueCrest Capital Management
Jersey
$229K +$236K +11,250 New
SFM
31
Sphera Funds Management
Israel
$220K +$227K +10,828 New
Norges Bank
32
Norges Bank
Norway
$203K +$210K +10,000 New
Tudor Investment Corp
33
Tudor Investment Corp
Connecticut
$203K +$210K +10,000 New
Morgan Stanley
34
Morgan Stanley
New York
$183K +$189K +9,000 New
TAM
35
Tiverton Asset Management
Delaware
$163K +$169K +8,039 New
PHK
36
Point72 Hong Kong
Hong Kong
$111K +$114K +5,446 New
FCM
37
Flinton Capital Management
Pennsylvania
$110K +$113K +5,406 New
TAM
38
Tyers Asset Management
Texas
$91K +$93.3K +4,452 New
NA
39
Neuburgh Advisers
California
$71K +$73.3K +3,498 New
MCIM
40
Meadow Creek Investment Management
Georgia
$52K +$53.3K +2,544 New
CSS
41
Cubist Systematic Strategies
Connecticut
$34K +$34.9K +1,665 New
UBS Group
42
UBS Group
Switzerland
$32K +$33.3K +1,586 New
RCM
43
Riverhead Capital Management
Delaware
$30K +$31.3K +1,495 New
TDC
44
Thompson Davis & Co
Virginia
$20K +$21K +1,000 New
Bank of America
45
Bank of America
North Carolina
$8K +$7.97K +380 New
CCA
46
Catalyst Capital Advisors
New York
$6K +$6.29K +300 New
1
2

EIDX Hedge Fund Activity: Q2 2018 in Review

45 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Eidos Therapeutics, Inc. Common Stock (EIDX) for Q2 2018, worth a combined $174M.

Buyers outnumbered sellers: 45 funds opened new EIDX positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $45.3M.

  • 45 institutional investors held Eidos Therapeutics, Inc. Common Stock (EIDX) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $174M of Eidos Therapeutics, Inc. Common Stock stock for Q2 2018.
  • 45 funds opened new Eidos Therapeutics, Inc. Common Stock positions in Q2 2018 and 0 closed out, a net change of +45 holders.
  • The largest Eidos Therapeutics, Inc. Common Stock buyer in Q2 2018 was RA Capital Management, an estimated $45.3M added.

Based on aggregated 13F filings for Q2 2018.